Reduced hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-alcoholic fatty liver disease

[1]  G. Calamita,et al.  Liver Glycerol Permeability and Aquaporin-9 Are Dysregulated in a Murine Model of Non-Alcoholic Fatty Liver Disease , 2013, PloS one.

[2]  Kai Xu,et al.  Reduced expression of aquaporin 9 in tubal ectopic pregnancy , 2013, Journal of Molecular Histology.

[3]  E. Füchtbauer,et al.  Liver-specific Aquaporin 11 knockout mice show rapid vacuolization of the rough endoplasmic reticulum in periportal hepatocytes after amino acid feeding. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[4]  G. Calamita,et al.  Water channel proteins in bile formation and flow in health and disease: when immiscible becomes miscible. , 2012, Molecular aspects of medicine.

[5]  B. Neuschwander‐Tetri,et al.  Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: A pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow‐up study , 2012, Hepatology.

[6]  G. Calamita,et al.  Biophysical assessment of aquaporin‐9 as principal facilitative pathway in mouse liver import of glucogenetic glycerol , 2012, Biology of the cell.

[7]  K. Cusi,et al.  The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.

[8]  G. Calamita,et al.  Estrogen prevents increased hepatic aquaporin-9 expression and glycerol uptake during starvation. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[9]  B. L. de Groot,et al.  Aquaporin-9 Protein Is the Primary Route of Hepatocyte Glycerol Uptake for Glycerol Gluconeogenesis in Mice* , 2011, The Journal of Biological Chemistry.

[10]  H. Makhlouf,et al.  Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver‐related mortality , 2011, Hepatology.

[11]  G. Frühbeck,et al.  Aquaglyceroporins serve as metabolic gateways in adiposity and insulin resistance control , 2011, Cell cycle.

[12]  P. Agre,et al.  Effects of acetaldehyde on hepatocyte glycerol uptake and cell size: implication of aquaporin 9. , 2011, Alcoholism, clinical and experimental research.

[13]  G. Calamita,et al.  Insulin- and leptin-mediated control of aquaglyceroporins in human adipocytes and hepatocytes is mediated via the PI3K/Akt/mTOR signaling cascade. , 2011, The Journal of clinical endocrinology and metabolism.

[14]  K. Widhalm,et al.  Nonalcoholic fatty liver disease: a challenge for pediatricians , 2010, International Journal of Obesity.

[15]  R. Sharpe,et al.  Explorer Aquaporin 9 expression in the developing rat epididymis is modulated by steroid hormones , 2017 .

[16]  R. Simó,et al.  Gene expression of paired abdominal adipose AQP7 and liver AQP9 in patients with morbid obesity: relationship with glucose abnormalities. , 2009, Metabolism: clinical and experimental.

[17]  J. Girard,et al.  The role of the lipogenic pathway in the development of hepatic steatosis. , 2008, Diabetes & metabolism.

[18]  G. Calamita,et al.  Altered expression and distribution of aquaporin-9 in the liver of rat with obstructive extrahepatic cholestasis. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[19]  S. Loft,et al.  Expression of Aquaporin 9 in Rat Liver and Efferent Ducts of the Male Reproductive System After Neonatal Diethylstilbestrol Exposure , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[20]  G. Frühbeck,et al.  Influence of Morbid Obesity and Insulin Resistance on Gene Expression Levels of AQP7 in Visceral Adipose Tissue and AQP9 in Liver , 2008, Obesity surgery.

[21]  S. Gradilone,et al.  LPS induces the TNF-alpha-mediated downregulation of rat liver aquaporin-8: role in sepsis-associated cholestasis. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[22]  G. Calamita,et al.  Present and future therapeutic strategies in non-alcoholic fatty liver disease , 2007, Expert opinion on therapeutic targets.

[23]  E. Füchtbauer,et al.  Defective glycerol metabolism in aquaporin 9 (AQP9) knockout mice , 2007, Proceedings of the National Academy of Sciences.

[24]  S. Kahn,et al.  Review: The role of insulin resistance in nonalcoholic fatty liver disease. , 2006, The Journal of clinical endocrinology and metabolism.

[25]  H. Cortez‐Pinto,et al.  Hepatic histology in obese patients undergoing bariatric surgery. , 2006, Journal of hepatology.

[26]  G. Frühbeck,et al.  Role of aquaporin‐7 in the pathophysiological control of fat accumulation in mice , 2006, FEBS letters.

[27]  G. Frühbeck,et al.  Aquaporin-7 and glycerol permeability as novel obesity drug-target pathways. , 2006, Trends in pharmacological sciences.

[28]  Michael Roden,et al.  Mechanisms of Disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical relevance , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[29]  K. Iguchi,et al.  Regulators for blood glucose level affect gene expression of aquaporin 3. , 2006, Biological & pharmaceutical bulletin.

[30]  G. Frühbeck.  Obesity: Aquaporin enters the picture , 2005, Nature.

[31]  M. Arrese,et al.  Predictors of Nonalcoholic Steatohepatitis (NASH) in Obese Patients Undergoing Gastric Bypass , 2005, Obesity surgery.

[32]  M. Ríos,et al.  Regulation of the immunoexpression of aquaporin 9 by ovarian hormones in the rat oviductal epithelium. , 2005, American journal of physiology. Cell physiology.

[33]  S. Genuth.  Lowering the criterion for impaired fasting glucose is in order. , 2003, Diabetes care.

[34]  J. Shaw,et al.  Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.

[35]  S. Tilghman,et al.  Glyceroneogenesis and the Triglyceride/Fatty Acid Cycle* , 2003, Journal of Biological Chemistry.

[36]  P. Agre,et al.  Aquaglyceroporin AQP9: Solute permeation and metabolic control of expression in liver , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Matsuda,et al.  Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9. , 2002, Diabetes.

[38]  D. Ribatti,et al.  Tissue Distribution and Membrane Localization of Aquaporin-9 Water Channel , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[39]  G. Frühbeck,et al.  Leptin‐induced lipolysis opposes the tonic inhibition of endogenous adenosine in white adipocytes , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  J. Frøkiaer,et al.  Immunolocalization of AQP9 in liver, epididymis, testis, spleen, and brain. , 2000, Biochemical and biophysical research communications.

[41]  S. Weremowicz,et al.  Functional and molecular characterization of the human neutral solute channel aquaporin-9. , 1999, American journal of physiology. Renal physiology.

[42]  F. Marumo,et al.  Cloning and functional expression of a new aquaporin (AQP9) abundantly expressed in the peripheral leukocytes permeable to water and urea, but not to glycerol. , 1998, Biochemical and biophysical research communications.

[43]  F. Marumo,et al.  Structure and chromosomal localization of a human water channel (AQP3) gene. , 1995, Genomics.

[44]  S. Locarnini.  Molecular virology of hepatitis B virus. , 2004, Seminars in liver disease.

[45]  E. Brunt.  Nonalcoholic Steatohepatitis: Definition and Pathology , 2001, Seminars in liver disease.